Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Choline chloride - Protara Therapeutics

Next Previous
Drug Profile

Choline chloride - Protara Therapeutics

Alternative Names: IV Choline Chloride - Protara Therapeutics; IV Choline Chloride for Injection - Protara Therapeutics

Latest Information Update: 19 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Protara Therapeutics
  • Class Antidementias; Ethanolamines; Hepatoprotectants; Neuroprotectants; Small molecules
  • Mechanism of Action Choline replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Liver disorders
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Liver disorders

Most Recent Events

  • 08 May 2025 Protara Therapeutics plans a registrational phase IIb/III THRIVE-3 trial in Liver disorders (In adolescents, In adults) in USA (IV) in the 3Q of 2025
  • 31 Dec 2024 Protara Therapeutics has patent protection for IV choline chloride in USA
  • 21 Oct 2024 Protara Therapeutics receives Fast Track designation for Liver disorders (In adolescents, In adults) (IV) in USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top